Section Arrow
PRPO.NASDAQ
- Precipio
Quotes are at least 15-min delayed:2026/04/29 21:19 EDT
Regular Hours
Last
 29.8
-1.95 (-6.14%)
Day High 
31.75 
Prev. Close
31.75 
1-M High
32.395 
Volume 
50.35K 
Bid
24.5
Ask
35
Day Low
29.14 
Open
31.19 
1-M Low
23.705 
Market Cap 
56.63M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 28.7 
20-SMA 27.81 
50-SMA 26.7 
52-W High 32.395 
52-W Low 5.94 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.23/0.39
Enterprise Value
59.64M
Balance Sheet
Book Value Per Share
8.16
Cash Flow
Cash Flow Yield
0.01
Income Statement
Total Revenue
24.05M
Operating Revenue Per Share
6.14
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NEONeoGenomics8.96-0.06-0.67%-- 
OPKOPKO Health1.11-0.1-8.26%-- 
DHRDanaher Corp178.8-0.18-0.10%34.69PE
QGENQiagen NV33.61-0.41-1.21%16.66PE
ICLRICON plc116.17+13.68+13.35%13.81PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. It focuses on improving cancer diagnostics, particularly hematologic malignancies. Its objective is to enhance diagnostic accuracy and accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, and Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division and the Products Division.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.